Diazepam Intramuscular (Im) / Intravenous (Iv) Injection Suppliers & Bulk Manufacturers
Available Forms: Intramuscular (IM) / Intravenous (IV) Injection
Available Strengths: 5 mg/mL
Reference Brands: Valium®(EU & US)
Category:
Antipsychotropic Drugs
Diazepam, a benzodiazepine, enhances GABAergic inhibition by binding to GABA-A receptors, leading to sedation, muscle relaxation, anxiolysis, and anticonvulsant effects. IM/IV formulations are used for status epilepticus, severe anxiety, muscle spasms, preoperative sedation, and alcohol withdrawal, offering rapid relief in emergency or acute care settings.
Diazepam IM/IV injection is an FDA-approved benzodiazepine for the treatment of status epilepticus, anxiety disorders, muscle spasms, and preoperative sedation. In the U.S., it is classified as a Schedule IV controlled substance. The EMA authorizes its use under centralized or national procedures in EU member states for similar indications. It is considered essential for emergency and critical care, with strict labeling and risk mitigation strategies in both markets. Regular pharmacovigilance reporting ensures compliance with safety standards.
Explore other diazepam formulations and global supply opportunities on Pharmatradz.com.
Diazepam Intramuscular (IM) / Intravenous (IV) Injection is available in Intramuscular (IM) / Intravenous (IV) Injection
and strengths such as 5 mg/mL.
Sourced from GMP-certified and ISO-compliant manufacturers, this API meets
global pharmacopeia standards (USP/EP/JP as applicable). Ideal for pharmaceutical
formulation and commercial manufacturing, Diazepam Intramuscular (IM) / Intravenous (IV) Injection is supplied in
bulk quantities with complete regulatory support including DMF, COA, and MSDS.
|
Technical Specifications & Supply Details
|
| Lead Time |
7 to 60 days (depending on batch size & schedule) |
| MOQ |
As per manufacturer’s batch size |
| COA |
Available with every batch |
| Regulatory Dossier / DMF |
Available upon request |
| Export Documentation |
FSC, COA, Manufacturing License, Product Permission |
| Standards |
IP, BP, USP |
| Certifications |
WHO-GMP, EU-GMP, USFDA (as applicable) |
Diazepam Intramuscular (IM) / Intravenous (IV) Injection can be exported to over 30 countries across Asia, Africa, Europe,
and Latin America. Flexible packaging, competitive pricing, and a verified supplier
network make Pharmatradz a trusted sourcing partner for pharmaceutical companies
and contract manufacturers worldwide.
Product Description:
Diazepam is a widely used benzodiazepine for managing anxiety, muscle spasms, seizures, and acute alcohol withdrawal symptoms. Available in tablets, oral solution, rectal gel, and IV/IM injection, Diazepam is marketed under brand names like Valium® and Diastat® in the US, and Valium® or Stesolid® in the EU. Strengths range from 2 mg to 10 mg for oral forms and 5 mg/mL for injectables. As a Schedule IV controlled substance in the US and prescription-regulated in the EU, Diazepam remains a crucial CNS pharmaceutical product. Ideal for B2B pharma suppliers seeking high-demand sedatives for regulated hospital and retail markets.
Disclaimer: By continuing to browse, you agree to the terms of use of this website and the Trade Marks displayed, in compliance with the provisions of the Trademark Act, 1999, Section 30 and 30(1) under 'Fair use.'
The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.
Back to Listing